Target motion management QA in 6D
The success of gating and tumor tracking requires rigorous QA and validation to meet the goal of better coverage of the target and sparing of organs at risk. The HexaMotion 6D Motion Platform uniquely uses the patient specific tumor motion pattern and replicates it in 6 dimensions.
Treat what you intend to treat
Intra-fractional movements of the tumour can cause large geometrical errors. This is especially true for tumours in the lung and the liver, but it has been shown* that even the prostate, which is often regarded as stable, can move considerably throughout treatment. If these geometrical errors are not handled correctly they can result in critical dosimetric errors.
This may result in the tumor volume receiving too little dose to achieve tumor control while organs at risk can receive too high dosage.
Ensure tumour control in moving targets
Verify motion effects using real tumour motions
Determine which patients require motion management
Validate the complete delivery chain